Catalyst Pharmaceutical Partners Inc buy Cantor Fitzgerald
Start price
22.03.24
/
50%
€14.55
Target price
22.03.25
€31.46
Performance (%)
64.12%
End price
23.03.25
€23.88
Summary
This prediction ended on 23.03.25 with a price of €23.88. The BUY prediction by Cantor_Fitzgerald for Catalyst Pharmaceutical Partners Inc saw massive gains of 64.12%. Cantor_Fitzgerald has a follow-up prediction for Catalyst Pharmaceutical Partners Inc where he still thinks Catalyst Pharmaceutical Partners Inc is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 3.131% | 3.131% | -8.871% |
| iShares Core DAX® | -1,66 % | -10,87 % | -0,72 % |
| iShares Nasdaq 100 | -3,77 % | -5,15 % | 13,41 % |
| iShares Nikkei 225® | -2,80 % | -11,30 % | 25,46 % |
| iShares S&P 500 | -2,30 % | -4,80 % | 8,94 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $34.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
In the thread Trading Catalyst Pharmaceutical Partners Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€22.79
06.06.25
06.06.25
-
06.06.26
06.06.26
-7.46%
16:32
16:32
Stopped prediction by Cantor_Fitzgerald for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€16.00
01.03.24
01.03.24
€31.37
01.03.25
01.03.25
39.63%
02.03.25
02.03.25